Cargando…

786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics

BACKGROUND: Recently, the first long-acting injectable (LAI) for the treatment of HIV was approved by the FDA. Although this advancement in therapeutics offers many potential advantages, including eliminating the needs for daily medications, the successful uptake into clinical settings will require...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorpe, Sara, Blatherwick, Donald, Uravich, Maria B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678662/
http://dx.doi.org/10.1093/ofid/ofad500.847
_version_ 1785150416066969600
author Thorpe, Sara
Blatherwick, Donald
Uravich, Maria B
author_facet Thorpe, Sara
Blatherwick, Donald
Uravich, Maria B
author_sort Thorpe, Sara
collection PubMed
description BACKGROUND: Recently, the first long-acting injectable (LAI) for the treatment of HIV was approved by the FDA. Although this advancement in therapeutics offers many potential advantages, including eliminating the needs for daily medications, the successful uptake into clinical settings will require navigating systems-level challenges such as clinic or hospital infrastructure. This study examined whether online continuing medical education (CME) focused on evidence-based best for incorporating long-acting injectables into clinical care would result in the adoption of new clinical practices. METHODS: Performance in the real world was assessed 30-60 days post-education for learners in the target audience(s). Email invitations were sent for the first 3 months of learners. Each respondent reported for each possible practice whether they were implementing for the first time or had modified it due to education, they were already doing it prior to education; or they were not doing it before or after education. They also indicated barriers they experience at least “some” of the time for each practice. The activity posted on 4/15/2022. Data was collection ended on 2/1/2023. RESULTS: There were a total of 39 learners consisting of PCPs, OB/GYNS, Nurses and NPs. Analysis showed that 80% of learners made a practice change or had practices reinforced due to education. Top 3 practice changes included:• 59% of learners are now educating eligible patients about the availability of LAI ART• 57% are staying abreast of current data from clinical trials, evaluating LAI ART for HIV• 56% are implementing LAI ART in clinical practice Survey results evidence persistent barriers to incorporating long-acting injectables into HIV Clinics. Top barriers included:• 38% Lack understanding of guidance about patient eligibility• 24% Lack knowledge of about best practices for getting started with LAI ART15% lack expertise in counseling patients on LAI ART CONCLUSION: The clinical practice changes identified in this assessment provide compelling evidence that participation in online CME/CE prompts adoption of changes in practice related to incorporating LAI ART in the care of people with HIV. Future education is needed to address the barriers identified in this assessment. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678662
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106786622023-11-27 786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics Thorpe, Sara Blatherwick, Donald Uravich, Maria B Open Forum Infect Dis Abstract BACKGROUND: Recently, the first long-acting injectable (LAI) for the treatment of HIV was approved by the FDA. Although this advancement in therapeutics offers many potential advantages, including eliminating the needs for daily medications, the successful uptake into clinical settings will require navigating systems-level challenges such as clinic or hospital infrastructure. This study examined whether online continuing medical education (CME) focused on evidence-based best for incorporating long-acting injectables into clinical care would result in the adoption of new clinical practices. METHODS: Performance in the real world was assessed 30-60 days post-education for learners in the target audience(s). Email invitations were sent for the first 3 months of learners. Each respondent reported for each possible practice whether they were implementing for the first time or had modified it due to education, they were already doing it prior to education; or they were not doing it before or after education. They also indicated barriers they experience at least “some” of the time for each practice. The activity posted on 4/15/2022. Data was collection ended on 2/1/2023. RESULTS: There were a total of 39 learners consisting of PCPs, OB/GYNS, Nurses and NPs. Analysis showed that 80% of learners made a practice change or had practices reinforced due to education. Top 3 practice changes included:• 59% of learners are now educating eligible patients about the availability of LAI ART• 57% are staying abreast of current data from clinical trials, evaluating LAI ART for HIV• 56% are implementing LAI ART in clinical practice Survey results evidence persistent barriers to incorporating long-acting injectables into HIV Clinics. Top barriers included:• 38% Lack understanding of guidance about patient eligibility• 24% Lack knowledge of about best practices for getting started with LAI ART15% lack expertise in counseling patients on LAI ART CONCLUSION: The clinical practice changes identified in this assessment provide compelling evidence that participation in online CME/CE prompts adoption of changes in practice related to incorporating LAI ART in the care of people with HIV. Future education is needed to address the barriers identified in this assessment. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678662/ http://dx.doi.org/10.1093/ofid/ofad500.847 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Thorpe, Sara
Blatherwick, Donald
Uravich, Maria B
786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics
title 786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics
title_full 786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics
title_fullStr 786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics
title_full_unstemmed 786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics
title_short 786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics
title_sort 786. online cme improves adoption of clinical practice related to incorporating long-acting injectables into hiv clinics
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678662/
http://dx.doi.org/10.1093/ofid/ofad500.847
work_keys_str_mv AT thorpesara 786onlinecmeimprovesadoptionofclinicalpracticerelatedtoincorporatinglongactinginjectablesintohivclinics
AT blatherwickdonald 786onlinecmeimprovesadoptionofclinicalpracticerelatedtoincorporatinglongactinginjectablesintohivclinics
AT uravichmariab 786onlinecmeimprovesadoptionofclinicalpracticerelatedtoincorporatinglongactinginjectablesintohivclinics